Charles River Laboratories | CRL - Pendapatan Penjualan





Penjualan Perubahan Tanggal
Agilent USD 1.84B 37M 2026-03
Align Technology USD 1.04B 10M 2026-03
Bio-Rad Laboratories USD 592.1M 101.1M 2026-03
Bruker USD 823.4M 153.8M 2026-03
Cardinal Health USD 60.9B 4.73B 2026-03
Charles River Laboratories USD 995.8M 1.6M 2026-03
Cigna USD 68.52B 3.95B 2026-03
Concord Medical Services Hldg CNY 200.61M 83.9M 2025-06
CVS Health USD 100.4B 5.3B 2026-03
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 880M 81M 2026-03
Elevance Health USD 49.5B 200M 2026-03
Humana USD 39.65B 7.13B 2026-03
Illumina USD 1.09B 70M 2026-03
Incyte USD 1.27B 240M 2026-03
Intrexon USD 717K 511K 2024-06
IQVIA Holdings USD 4.15B 210M 2026-03
Laboratory Of America USD 3.54B 20M 2026-03
Lakefront Biotherapeutics EUR 6.5M 894.32M 2026-03
Lonza CHF 3.58B 63M 2025-06
McKesson USD 92.3B 13.86B 2026-03
Merck EUR 5.13B 120M 2026-03
Mettler Toledo International USD 947.13M 182.87M 2026-03
Novartis USD 13.11B 226M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Quest Diagnostics USD 2.9B 90M 2026-03
Revvity USD 711M 61.06M 2026-03
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
United Therapeutics USD 781.5M 8.7M 2026-03
UnitedHealth USD 111.7B 1.5B 2026-03
Veradigm USD 142.52M 9.38M 2022-12
Waters USD 1.27B 338M 2026-03
West Pharmaceutical Services USD 844.9M 39.9M 2026-03